More positive news from Clinuvel, at some point the market is going to need to price all of this in. I look forward to that rerate
Such a quality company can't remain unnoticed and unloved forever, but when they're unloved is the best time to be buying imo (for some reason most investors prefer to wait till they become loved and have already rallied several hundred percent)
Ann: SCENESSE European Orphan Drug Designation for VP, page-7
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.05 |
Change
0.100(0.67%) |
Mkt cap ! $755.1M | |||
| Open | High | Low | Value | Volume |
| $14.91 | $15.19 | $14.71 | $826.7K | 55.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 246 | $15.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.05 | 161 | 7 |
View Market Depth
| Last trade - 14.41pm 01/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |